Phase 3 Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 85 years of age, of any gender
- People who have been diagnosed with an ischemic stroke (a stroke caused by a blocked blood vessel) according to standard Western medical criteria
- People who also meet the Traditional Chinese Medicine diagnosis for stroke (known as "Zhongfeng")
- People whose stroke symptoms began no more than 72 hours before their diagnosis
- People whose stroke severity falls within a specific range on a standard medical scale called the NIHSS, scoring between 4 and 25 points (confirm with trial site)
- People experiencing their first stroke, or whose previous stroke left no significant lasting effects
- People (and their legal guardian, if applicable) who are willing to sign a consent form agreeing to take part in the study
Who may not be able to join:
- People whose brain scans show conditions with similar symptoms to stroke, such as brain tumours, brain infections, or bleeding in or around the brain
- People with significantly abnormal liver or kidney function test results above specific levels (confirm with trial site)
- Elderly people who are considered physically frail, or people who currently have an infection
- People with a history of mental illness or dementia
- People with serious disease affecting other major organs, any type of cancer in any part of the body, people currently receiving cancer treatment, or people whose life expectancy is less than 6 months
- People with a significant history of drug or alcohol misuse
- Women who test positive for pregnancy during screening, who plan to become pregnant during the trial, or who are currently breastfeeding
- People who are currently taking part in another clinical trial, or who have done so within the past month
- People who are currently taking a type of medication called a cholinesterase inhibitor, or who have taken one within the past 3 months (confirm with trial site)
- People with certain pre-existing health conditions including epilepsy, movement disorders, bowel obstruction, asthma, chest pain (angina), a slow heart rate, or glaucoma
- People for whom an MRI brain scan is not safe, such as those with a pacemaker, certain metal implants, or severe claustrophobia
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chunxiang Chen, Shanghai Yueyang Integrated Medicine Hospital
Phone: +8618616537797
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The change in NIHSS score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.